Free Sale and Export Certificates: Singapore’s Role as a Regional Hub

1. Key takeaways

HSA can issue a Free Sale Certificate or an Export Certificate for products that qualify. The official fee is SGD 57 for the application, with a review period of 14 working days, plus a handling fee of SGD 57 for each device and each country. Because Singapore is a regional headquarters hub in Southeast Asia, these certificates are often used to support registration applications in third-country markets. The certificate proves that a product may be freely sold in Singapore; it does not prove anything about the target market, and its usefulness depends entirely on whether that market accepts a Singapore certificate as evidence.

• Two documents, one service. Free Sale Certificate and Export Certificate are issued by HSA through the same route.
• Fee structure is layered. SGD 57 for the application, then SGD 57 per device and per country as a handling fee.
• Fourteen working days for issue. The review period applies to the application, not to the target country’s own approval process.
• Legal marketing comes first. The product must already be registered in Singapore, or exempt with a product notification filed, and the holder must have a valid licence.
• Acceptance is country-specific. A certificate is only useful where the receiving regulator recognises Singapore as an acceptable source.
• Not a reference agency approval. HSA is not on its own list of reference agencies for Singapore registration.

2. Legal basis

The service is described on the HSA Manufacturing, import and supply page under Free Sale Certificate and Export Certificate, and the fee appears on the HSA official fees page. It operates alongside two other regimes rather than independently of them: product registration under GN-15 R15, which establishes that the device may be supplied in Singapore, and dealer licensing under GN-02 R8, which establishes that the applicant may carry on the relevant activity. The certificate is therefore a derivative document. It reports a status created by the registration and licensing system, and it cannot create that status where it does not already exist.

3. Expert insights

The fee is an application fee plus a per-unit charge, so multi-product and multi-country requests multiply. An application costs SGD 57, and then each device and each country attracts a further SGD 57. Take three devices for two countries: that is six billable units, so the handling fee is 6 multiplied by SGD 57, or SGD 342, and with the SGD 57 application fee the total is SGD 399. A budget for a multi-country rollout has to be built on units rather than on the application alone, otherwise the first consolidated request will exceed the figure that was approved.

The value of a Free Sale Certificate depends on whether the target country accepts Singapore’s certificate. This is the core point. The certificate is not a universal passport. Whether a third-country regulator accepts it depends on whether that country lists Singapore as an acceptable reference or certifying source. Before planning to use a Singapore certificate to support registration elsewhere, the target country’s requirements should be confirmed in writing, because the certificate itself says nothing about the receiving regulator’s policy. We have seen companies obtain a batch of certificates and then discover that the intended destination did not recognise them, which converts the fee into a pure cost with no regulatory return.

Singapore’s regional hub position does create practical advantages. The city concentrates a large number of regional headquarters of multinational device companies, its regulatory system is aligned with AMDD, it works in English as a single language, and its certification process is standardised. For a manufacturer outside China that needs a third-party official certificate in English, a Singapore Free Sale Certificate is a credible document, and the 14 working day issue period is predictable enough to be planned into a filing sequence. Those advantages are real, but they operate at the level of credibility and speed rather than at the level of legal obligation in the target market.

Issue normally presupposes that the product is lawfully marketed in Singapore. The nature of a Free Sale Certificate is to confirm that the product may be freely sold in Singapore. That normally requires the product to be registered, or to be exempt with a product notification completed, and it requires the holder to have a valid licence. The causal order runs from Singapore marketing to certificate, and it cannot be reversed. A company that plans to obtain a certificate first and arrange registration afterwards will find that the application has nothing to certify, and the time spent on the certificate is time lost from the registration project.

A Free Sale Certificate should not be confused with reference agency approval. A Singapore Free Sale Certificate or Export Certificate cannot serve as reference agency approval within Singapore’s own registration pathway. The list of reference agencies comprises TGA, Health Canada, Japan, the US FDA, EU notified bodies and Malaysia’s MDA, and it does not include HSA itself. The distinction matters when a company assumes that a certificate issued by HSA strengthens a Singapore submission. It does not, because the Singapore route looks to approvals granted by other named agencies, not to documents issued by the authority receiving the application.

4. Practical recommendations

• Confirm acceptance before applying. Establish that the target country recognises a Singapore Free Sale Certificate, then decide whether to proceed.
• Calculate by device and country. Use SGD 57 for the application plus SGD 57 per device-country unit when building the budget.
• Secure Singapore marketing status first. Complete registration or the applicable notification, and confirm the holder’s licence is valid.
• Align names and models across documents. The product name and model must match the registration record and the target country filing.
• Do not use a certificate to substitute for reference agency approval. The Singapore pathway recognises approvals from other named agencies, not HSA documents.

5. Verification checklist

• □ The target country accepts a Singapore Free Sale Certificate
• □ The product is registered in Singapore, or exempt with a notification completed
• □ The holder’s licence is valid
• □ Fees have been calculated as SGD 57 plus SGD 57 per device-country unit
• □ Product names and models match the registration record
• □ The 14 working day issue period is reflected in the filing schedule

Regulatory information verified as of 26 October 2026. Source tiers: secondary (HSA manufacturing, import and supply page; HSA fees page).

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Singapore. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with HSA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com